Not “One” Myeloma, Truly Multiple

Not “One” Myeloma, Truly Multiple

There is so much information being produced and shared at the American Society of Hematology (ASH) Annual Meeting, it is challenging to digest it all and distill it down. In review of the many screen shots I took of the presentation slides, one piece of information...
Post-ASH Reflection: Hope

Post-ASH Reflection: Hope

Hope is important because it can make the present moment less difficult to bear. If we believe that tomorrow will be better, we can bear a hardship today. –Thich Nhat Hanh  Reflecting on the opportunity I had to attend the 64th American Society of Hematology...
“Pre-ASH” ASH, Days 1 & 2

“Pre-ASH” ASH, Days 1 & 2

Hello Myeloma Community. It is time for an update from the 64th American Society of Hematology (ASH) Annual Meeting. Arriving on Thursday, I had the opportunity to spend time with my dear friend, Angela Dispenzieri as we walked around the French Quarter and took in...
Significance of the Last Decade

Significance of the Last Decade

In some ways, a decade seems like a lifetime, but in other ways time flies by. 2013 was my first American Society of Hematology (ASH) Annual Meeting. That annual meeting, like the one this year, was held in New Orleans. The location may have been the same, but the...
The Changing of the Targets

The Changing of the Targets

Targets in myeloma are interesting and hopeful for our futures as bispecific antibodies continue to become a key treatment option. Using the immune system to fight multiple myeloma makes great sense to me. It’s exciting to follow trials targeting BCMA as part of the...